FANCD2 (ID 2177) Trilencer-27 Human siRNA 
| Catalog No. | Description | | Availability* | | | SR301519 | - FANCD2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 2177)
- Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmol
- Included - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml
| | In Stock | | | TT300001 | SiTran1.0: Transfection reagent designed for RNAi duplex (0.5 ml)
Free! With the purchase of 2 siRNA kits (save ) | | In Stock | | * These siRNA duplexes were designed to be effective against all transcriptional variants at this gene locus.
 Also for FANCD2 (Locus ID 2177)  OriGene Data | Amount: | 2 nmol each, lyophilized | Purity: | HPLC purified | | Quality Control: | Tested by ESI-MS | Sequences: | Available with shipment | | Stability: | One year from date of shipment when stored at -20 ºC | Shipment: Ambient | | # of transfections: | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM) | Reference Data | RefSeq: NM_001018115 NM_033084 | | Synonyms: FA-D2; FA4; FACD; FAD; FAD2; FANCD | | Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]. | |
Performance Guranteed: OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency.
For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at tech@clinisciences.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required). siRNA Citations:
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation, Lue Dai, Kristy B. Lidie, Qian Chen, Joseph W. Adelsberger, Xin Zheng, DaWei Huang, Jun Yang, Richard A. Lempicki, Tauseef Rehman, Robin L. Dewar, Yanmei Wang, Ronald L. Hornung, Kelsey A. Canizales, Stephen J. Lockett, H. Clifford Lane, and Tomozumi Imamichi, J. Exp. Med., Mar 2013; 210: 517 - 534. [SPTBN1 ]
Protein Kinases D2 and D3 Are Novel Growth Regulators in HCC1806 Triple-negative Breast Cancer Cells, QIN HAO, RAYMOND MCKENZIE, HUACHEN GAN, and HUA TANG, Anticancer Res, Feb 2013; 33: 393 - 399. [PRKCA]
Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway, Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic, and Des R. Richardson, Mol. Pharmacol., Feb 2013; 83: 454 - 469. [ROCK1 ]
Taxifolin Enhances Andrographolide-Induced Mitotic Arrest and Apoptosis in Human Prostate Cancer Cells via Spindle Assembly Checkpoint Activation , Zhang ZR, Al Zaharna M, Wong MM, Chiu SK, Cheung HY., PLoS One. 2013;8(1):e54577 [MAD2L1 ]
miR-23b Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in Prostate Cancer, Shahana Majid, Altaf A. Dar, Sharanjot Saini, Sumit Arora, Varahram Shahryari, Mohd Saif Zaman, Inik Chang, Soichiro Yamamura, Yuichiro Tanaka, Guoren Deng, and Rajvir Dahiya, Cancer Res., Dec 2012; 72: 6435 - 6446. [SRC ]
cAMP-responsive Element Modulator a (CREMa) Contributes to Decreased Notch-1 Expression in T Cells from Patients with Active Systemic Lupus Erythematosus (SLE), Thomas Rauen, Alexandros P. Grammatikos, Christian M. Hedrich, Jürgen Floege, Klaus Tenbrock, Kim Ohl, Vasileios C. Kyttaris, and George C. Tsokos, J. Biol. Chem., Dec 2012; 287: 42525 - 42532. [NOTCH1]
The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer, Tiantian Cui, Yuan Chen, Linlin Yang, Thomas Knösel, Otmar Huber, Manuela Pacyna-Gengelbach, and Iver Petersen, Carcinogenesis, Dec 2012; 33: 2326 - 2333. [DSC3]
A possible gene silencing mechanism: Hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells , D Guo, B Wu, J Yan, X Li, H Sun, D Zhou, Biochem Biophys Res Commun. 2012 Nov 9;428(1):80-5 [SP1]
cAMP response element modulator a controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus, Christian M. Hedrich, Jose C. Crispin, Thomas Rauen, Christina Ioannidis, Sokratis A. Apostolidis, Mindy S. Lo, Vasileios C. Kyttaris, and George C. Tsokos, PNAS, Oct 2012; 109: 16606 - 16611. [DNMT3a]
Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/ß-catenin signaling pathway in human lung cancer, Linlin Yang, Yuan Chen, Tiantian Cui, Thomas Knösel, Qing Zhang, Kai Frederik Albring, Otmar Huber, and Iver Petersen, Carcinogenesis, Oct 2012; 33: 1863 - 1870. [DSP] More siRNA Citations >> | Researchers who bought this siRNA have also purchased: |
|
| Related Transfection Reagent Related Primer Pair |
| Product Manuals
MSDS
FAQs
* Delivery time is an estimate in business days. Occasional delays may occur due to unforeseen complexities in the preparation of your construct. International customers may expect an additional 1-2 weeks in shipping |
